Cargando…
Alternative RNA Splicing in Fatty Liver Disease
Alternative RNA splicing is a process by which introns are removed and exons are assembled to construct different RNA transcript isoforms from a single pre-mRNA. Previous studies have demonstrated an association between dysregulation of RNA splicing and a number of clinical syndromes, but the genera...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953061/ https://www.ncbi.nlm.nih.gov/pubmed/33716968 http://dx.doi.org/10.3389/fendo.2021.613213 |
_version_ | 1783663856302686208 |
---|---|
author | Wu, Panyisha Zhang, Moya Webster, Nicholas J. G. |
author_facet | Wu, Panyisha Zhang, Moya Webster, Nicholas J. G. |
author_sort | Wu, Panyisha |
collection | PubMed |
description | Alternative RNA splicing is a process by which introns are removed and exons are assembled to construct different RNA transcript isoforms from a single pre-mRNA. Previous studies have demonstrated an association between dysregulation of RNA splicing and a number of clinical syndromes, but the generality to common disease has not been established. Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease affecting one-third of adults worldwide, increasing the risk of cirrhosis and hepatocellular carcinoma (HCC). In this review we focus on the change in alternative RNA splicing in fatty liver disease and the role for splicing regulation in disease progression. |
format | Online Article Text |
id | pubmed-7953061 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79530612021-03-13 Alternative RNA Splicing in Fatty Liver Disease Wu, Panyisha Zhang, Moya Webster, Nicholas J. G. Front Endocrinol (Lausanne) Endocrinology Alternative RNA splicing is a process by which introns are removed and exons are assembled to construct different RNA transcript isoforms from a single pre-mRNA. Previous studies have demonstrated an association between dysregulation of RNA splicing and a number of clinical syndromes, but the generality to common disease has not been established. Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease affecting one-third of adults worldwide, increasing the risk of cirrhosis and hepatocellular carcinoma (HCC). In this review we focus on the change in alternative RNA splicing in fatty liver disease and the role for splicing regulation in disease progression. Frontiers Media S.A. 2021-02-26 /pmc/articles/PMC7953061/ /pubmed/33716968 http://dx.doi.org/10.3389/fendo.2021.613213 Text en Copyright © 2021 Wu, Zhang and Webster http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Wu, Panyisha Zhang, Moya Webster, Nicholas J. G. Alternative RNA Splicing in Fatty Liver Disease |
title | Alternative RNA Splicing in Fatty Liver Disease |
title_full | Alternative RNA Splicing in Fatty Liver Disease |
title_fullStr | Alternative RNA Splicing in Fatty Liver Disease |
title_full_unstemmed | Alternative RNA Splicing in Fatty Liver Disease |
title_short | Alternative RNA Splicing in Fatty Liver Disease |
title_sort | alternative rna splicing in fatty liver disease |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953061/ https://www.ncbi.nlm.nih.gov/pubmed/33716968 http://dx.doi.org/10.3389/fendo.2021.613213 |
work_keys_str_mv | AT wupanyisha alternativernasplicinginfattyliverdisease AT zhangmoya alternativernasplicinginfattyliverdisease AT websternicholasjg alternativernasplicinginfattyliverdisease |